Polymorphic arylamine N-acetyltransferase (NAT2) genotyping was determined among 127 unrelated apparently healthy Omanis. The seven known mutations of NAT*2 gene namely, G 191 A, C 282 T, C 341 T, C 481 T, G 590 A, A 803 G and G 857 A were detected using PCR-RFLP analysis. Eleven allele variants (3 alternative) and 30 different genotypes were determined. The commonest alleles were found to be NAT*5B, NAT2*6A and NAT*4 with corresponding frequencies of 0.362, 0.248 and 0.189 respectively. The overall ratio of slow acetylator alleles was 0.25. A new allele variant containing G 590 A, C 282 T and T 341 C mutations was found in one subject (proposed name NAT*2 5G). The commonest genotypes were found to be 5B/5B, 5B/6A, 4/5B, 4/6A with frequencies 0.165, 0.157, 0.118, 0.110 and 0.079 respectively. Objective: To establish a methodology for rapid detection and sub-typing of HPV in biomedical samples. Method: We utilized the Piezoelectric Genesensor(PG) technique, which was a combination of the Piezoelectric Biosensor and Gene Chips to detect bacteria and virus. We used AT-cut, 10 MHz piezoelectric crystals(PEC) for the immobilization of single stranded nucleic acid and the subsequent hybridization reactions. This system is based on detecting small changes in mass on the surface of a PEC which occur upon immobilizing azido containing probe nucleic acid on the surface and hybridizing complementary target nucleic acid to previously immobilized probe. In our work an array of piezosensors and a computer-controlled system of multichannel measurement and data acquisition construct this instrumentation for multisample clinical testing. The array, a microwell-like plate, is composed of 12 piezosensor, one of which is used as a reference well, and others are used as sample wells. The frequency shift between each sample and the reference sensor is measured in real-time and saved for later data processing. As a medical diagnostic application, we used the PG to establish a methodology for rapid detection and sub-typing of HPV in 22 cases of recurrent biopsy and 22 cases of corresponding original biopsy specimens. The detection of HPV by means of PG was compared with conventional methods , PCR and Dot Blot hybridization. Result: In the 22 recurrent cases, 15 specimens cases had HPV6 DNA, 2 contained HPV11 DNA and 4 harbored HPV16 DNA. Only one case was negative. In the 22 original cases, all were positive: 17 specimens harbored HPV6 DNA, 3 contained sequence homologous HPV11 DNA, and 2 harbored HPV16 DNA. No HPV18 DNA was detected in any specimen. When compared with the PCR and Dot blot analysis, the results were essentially the same except one case, which was shown to contain other sub-typing of HPV . Conclusion: Our results showed that piezoelectric genosensor technique is a rapid and specific method to analyze HPV. Objective: To establish a methodology for rapid quantification of total human IgE. Method: We utilize the piezoelectric sensor array technique, modifying the piezoelectric crystal with an specific antibody, to detect human IgE. In our work, an array of piezosensors and a computer-controlled system of multichannel measurement and data acquisition construct this instrumentation for multisample clinical testing. The array, a microwell-like plate, is composed of 12 piezosensor, one of which is used as a reference well, and others are used as sample wells. The frequency shift between each sample and the reference sensor is measured in real-time and saved for later data processing. When reaction between antibody and antigen happen, there will be small changes in mass on the surface of piezoelectric crystal, which will result in frequency decrease of piezoelectric sensor . The frequency decrease depended on the concentration of the IgE . The quantification of total human IgE by means of piezoelectric sensor array technique was compared with conventional radioimmunosorbent test. Result: The piezoelectric sensor array technique can quantitatively detect human serum IgE in the range of 18ϳ310 IU/m, and the detection limit is 7.1 IU/ml. A total of 28 serum samples are detected by this new method and the results agree well with those given by radioimmunosorbent test, the correlation coefficient is 94%. Conclusion Our results showed that piezoelectric sensor array technique is a accurate rapid and sensitive method for quantification of total human IgE. Objective: To investigate the frequency distribution of vitamin D receptor-(VDR) genotype in Chinese population and evaluate the correlation between VDR gene polymorphisms and bone mineral density(BMD). Methods: Polymerase chain reaction(PCR) and restriction analysis were used to determine VDR genotypes in 148 Chinese women. Their L 2-4 lumbar spine BMD was measured by dual-energy X-ray absorptiometry(DEXA). Results: The frequency distribution of the VDR genotype was : BB, 2.7%; Bb, 8.1%; bb, 89.2%. The BMD in perimenopasal women of different genotypes were 1.123Ϯ0.105g/cm 2 (BB), 1.290Ϯ0.141g/cm 2 (Bb) and 1.185Ϯ0.130g/cm 2 (bb) respectively. The BMD was significantly lower in postmenopausal women than perimenopausal women (pϽ0.01). The incidence of osteoporosis in postmenopausal women is 34%. Conclusion: The frequency distribution of the VDR genotype in Chinese peri-and postmenopausal women were apparently from Western countries. The correlation between the VDR genotype and BMD was not found.
In many instances, multiple analysis of a single sample is desirable. However, when the sample size or content is limited, this becomes difficult or impossible. Multiplex amplification such as PCR, and particularly Isothermal Amplifications is very difficult, and is severely limited in providing a large number of assays simultaneously. The Xtra Plex approach is a novel method for boosting the amount of input starting material for distribution among large numbers of individual analyses. It involves multiple, sequential rounds of Limited, Multiplex Amplification from archived nucleic acid bound irreversibly to a solid-phase binding material (Xtra Amp tubes) as the boosting method. Output from these initial rounds of multiplex amplifications are distributed into the several single, subsequent analyses. This has been demonstrated with PCR and NASBA. Using 25 distinct PCR primer pairs targeting human genes, five sequential rounds of five primers each have been performed using this technique with no loss of performance relative to simplex reactions. In a separate experiment, 20 primer pairs have simultaneously been used in a single booster multiplex from one extraction in an Xtra Amp tube with identical results. In another set of experiments, twelve sequential rounds of booster/secondary PCR amplifications have been performed from the same blood extraction in the same Xtra Amp tube targeting the same gene and using the same primer set.
Ten simultaneous, NASBA reactions were performed in a single booster multiplex, with the product from this booster reaction supplying ten subsequent simplex NASBA reactions. Eight of these ten reactions worked with no optimization for multiplexing. In two sequential rounds of five primer set multiplex NASBAs from the same extraction in an Xtra Amp tube gave nine of ten successful secondary simplex NASBA reactions.
By taking advantage of the irreversible binding capacity of Xtra Amp tubes for Nucleic Acids, and by performing multiplex booster amplifications followed by numerous secondary simplex amplifications, a very large number of assays can be performed on a very limited or precious sample. The polymerase chain reaction (PCR) has proven to be a powerful nucleic acid amplification method to generate high yields of DNA. The Transcription Mediated Amplification (TMA) technology has demonstrated its ability to amplify nucleic acids to generate high yields of RNA. Both techniques are designed to amplify specific nucleotide sequences in an exponential manner, thus providing a basis for sensitive diagnostic assays. In the TMA method, in addition to exponential increase in RNA, the reverse transcriptase activity effects a moderate increase in cDNA copies. Here we describe a combination of TMA and PCR methods to generate an extremely efficient and sensitive amplification method, especially useful when sample size is limited. In addition, the potential for RNA contamination is much easier to control than for DNA. Detection of the PCR amplification product can be performed in closed contained systems such as the Taqman or Cobas analyzers.
We demonstrate the efficacy and sensitivity of this assay for the detection of HCV RNA molecules in infectious plasma. The TMA reagents were used to capture HCV RNA, to reverse transcribe and generate high yields of specific RNA molecules and concomitant intermediate yields of cDNA. An aliquot of this was used as starting material for PCR amplification. As few as 3 copies of HCV RNA could be detected using as little as 0.3 ml of plasma for the TMA amplification.
This method should be applicable for detection, quantitative estimations and analytical systems. It should be useful in detection techniques requiring sensitive diagnosis of infectious agents; quantitative analysis in clinical trials, in gene expression analyses, and in analytical systems involving DNA typing for forensic analysis, archeological sampling and diagnosis. For analytical studies requiring resolution of amplified DNA by agarose gels for forensic, archeological, and single nucleotide polymorphisms, the usual precautions to prevent contamination should be observed.
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Homogeneous PCR Screening Assay for Human Parvovirus B19. Jay Ji 1 , Xiuli Chen 1 , Mark Manak 1 , Sandra Randall 2 , and Glenn Nardone 2 , 1 BBI Biotech Research Lab, Gaithersburg, MD 20877; 2 Intergen Company, Gaithersburg, MD 20877. A rapid, reliable and quantitative DNA test for human parvovirus B19 is needed by the blood industry to prevent B19 transmission through blood and plasma derived products. Quantitative determination of parvovirus B19 DNA is also important for monitoring viral load in infected patients. We have developed a PCR-based closed-tube fluorescent assay for the detection of human parvovirus B19 suitable for high throughput viral diagnostics and blood screening. Parvovirus DNA purified from plasma or whole blood is amplified with energy transfer Amplifluor™ primers specific for B19. An internal DNA control is designed to monitor sample recovery and PCR inhibitors using a primer with a different fluorophore. A multiplex system is developed to detect the B19 and internal control sequences simultaneously. Ten copies per assay, equivalent of 100 copies per ml, were detected consistently in endpoint analysis and quantitated accurately in real-time PCR with the two-color system. DNA extraction using the Qiagen BioRobot following by PCR amplification and detection in a Perkin Elmer PE7700 allow for rapid screening and quantitation of samples within a 4-hour period. Even more rapid screening can be achieved by endpoint analysis using a fluorescent plate-reader. The newly developed Amplifluor™ assay for parvovirus B19 detection can be adapted for use as a highly sensitive and robust screening method for blood or blood products.
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Detection of High-Risk Human Papillomavirus with Peptide Nucleic Acid Probes. M.A. Cohenford, J. Williams, C. Chapron, and B.B. Lentrichia, Cytyc Corporation, Boxborough, MA. Introduction: Strong evidence linking the development of cervical cancer with infection by specific types of human papillomavirus (HPV) has encouraged research in methods for HPV testing. PNA (Peptide Nucleic Acids) are a new class of synthetic molecules that mimic nucleic acids. Unlike negatively charged nucleic acids PNA has a neutral backbone. It is this neutral backbone of PNA that allows PNA:DNA duplexes to have stronger affinity and greater discriminating power than the corresponding nucleic acid duplexes.
Objective: The objective of this study was exploit the high affinity of PNA for DNA to develop short PNA sequences capable of distinguishing the broad range of pathogenic HPV types from the most common benign forms.
Materials and Methods: Biotinylated PNA probes were synthesized to specification. Specificity of the PNA probes was determined by Southern hybridization employing genotyped HPV infected specimens collected and stored in PreservCyt™ Solution (Cytyc Corporation, Boxborough, MA). Genotyping of HPV was performed by PCR-RFLP analysis using a consensus primer set and by specific HPV DNA typing probes. DNA isolated from PreservCyt specimens was amplified by PCR using the MY09/MY11 primers and used for Southern Blot hybridization. PNA:DNA hybrids were detected in Southern blots using streptavidin alkaline phosphatase and a chemiluminescent substrate.
Results: Of the five PNA probes that were evaluated, only two probes proved specific for their DNA targets; PNA probes 16 and 35. The HPV 33 directed PNA probe reacted with HPV DNA types 6, 11, 18, 33, 52, and 58. The HPV 18 directed PNA probe reacted strongly with HPV DNA types 16 and 18, and moderately with HPV DNA 35 and 39. The HPV 45 directed PNA probe reacted with HPV genotypes 39 and 68 as well as with type 45.
Conclusion: Short PNA sequences (14-15 mer) can be used to capture a broad range of pathogenic HPV genotypes to aid in the management of cervical dysplasia.
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Higher Factor VII Q Allele Frequencies in Indians and Two Novel Variants of Hypervariable Region of Noncoding Region Found. Lily Chiu 1 , Khaw Min Cheh 2 , Leow Chui Li 1 , Evelyn S.C. Koay 1,2 , 1 Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital; 2 Department of Pathology, National University of Singapore.
Background: The human coagulation factor VII (FVII) gene on chromosome 13q34 consists of 9 exons and 8 introns spanning 12.8 kb. Elevated FVII activity (FVIIc) in blood has been shown to be associated with increased risk of ischaemic cardiovascular diseases (CVD), thrombosis and myocardial infarction (MI). The R353Q (MspI) polymorphism of FVII gene has been reported to be strongly associated with plasma FVIIc in healthy individuals from the UK (pϽ0.0001). The single nucleotide polymorphism (G3 A) at codon 353 leads to replacement of arginine(R) with glutamine(Q). We had previously reported the allele frequencies of the Q allele to be 0.04, 0.10 and 0.22 for Chinese, Malays and Indians, respectively. The higher allelic frequencies of the Q allele, which predisposes to lower levels of FVIIc, in Indians may explain the higher incidence of cardiovascular diseases among them. Another polymorphism in the hypervariable region 4 of intron 7 has been report associated with increased FVIIc. There are 8 of these noncoding regions with tandem repeats of 37 bp monomers. H6 (443 bp with 6 monomers) is the most common variant, H7 (480 bp with 7 monomers) is a less frequent variant, and H5 (405 bp with 5 monomers) is rare. The H7H5 and H6H5 genotypes are associated with the highest risk of MI, followed by the H6H6, H6H7 and H7H7 genotypes (pϽ0.001). Results: We genotyped 291 healthy Singaporeans (99 Indians, 100 Malays, 92 Chinese). Our results showed that the most frequent genotype was H6H7 (Indians:48.5%, Malays:50%, Chinese:52.3%), followed by H6H6 (Indians: 33.3%, Malays:26%, Chinese:26.1%) and H7H7 (Indians:16.2%, Malays:22%, Chinese: 18.5%). We also found 2 novel variants which were Ͼ480 bp long in 2 Chinese individuals with genotypes H6H9 and H7H10 (heterozygotes with 9 and 10 repeated monomers, respectively, as confirmed by DNA sequencing). The functional significance of these new variants is not known.
Microarray technologies have revolutionized the analysis of gene expression and DNA sequence. In microarray applications, nucleic acids are typically labeled with fluorescent dyes and hybridized to cDNAs or oligonucleotides configured on a solid surface. Fluorescent signals are detected and interpreted using a confocal laser fluorescence scanner and image analysis software. In practice, limited sensitivity, poor signal reproducibility and expensive instrumentation often encumber the performance and accessibility of many microarray systems.
To address these microarray system performance issues, we have applied Resonance Light Scattering (RLS) particle technology, a novel, ultra-sensitive and simple signal generation and detection system (1,2 ), to microarrays. Submicroscopic RLS gold and silver particles of uniform dimension (40 -140 nm diameter range) scatter incident white light to generate highly intense monochromatic light. The colored light signal generated by an RLS particle is 10 4 to 10 6 times greater than the signal emitted from sensitive fluorophores. RLS signal does not photobleach and different colors and intensities of the generated scattered light can be accurately predicted by application of algorithms derived from electromagnetic radiation theory. On solid surfaces, RLS signal can be detected by the unaided eye at particle densities as low as 0.01 to 0.003 particles/m 2 . RLS particles can be derivatized with a variety of molecules for analytical bioassays including proteins, antibodies, small molecule ligands and nucleic acid probes. Once derivatized, RLS particles are highly selective for detection of specific biomolecular targets. Simple detection instrumentation consisting of an illumination source, configured optics, CCD-video camera and image analysis system has been developed for microarrays. The optical properties and practical application of RLS particles for microarray systems will be presented. Detection and mapping of genes amplified in tumors are important for the basic understanding of tumorigenesis and the prediction of the tumor biological behavior. Comparative genomic hybridization (CGH) was developed for genome-wide analysis of DNA sequence copy number alterations in a single experiment. CGH using metaphase chromosomes, however, has a limited mapping resolution. Microarray technology enables hybridization to an array of mapped known genes instead of metaphase chromosomes, offering an ideal means of achieving increased mapping resolution and directly associating gene copy number alterations with the initiation and development of a tumor. In this study, we used a microarray-based CGH technique to search for amplified genes in 15 tumor specimens including 6 pulmonary artery intimal sarcomas (PAIS) and 9 adrenocortical tumors (ACT) which were selected for based on our CGH studies on a series of 43 tumors. Tumor and normal genomic DNAs, which were labeled with the fluorophore dyes Alexa488 Green-dUTP and Alexa594 Red-dUTP, respectively, were cohybridized to microarrays containing 58 oncogene targets (Vysis, Downer Grove, IL). In CGH analyses, all 6 PAISs consistently showed gains or amplifications of 12q13-q15. Of the 9 ACTs, 2 exhibited amplifications of this region, too. Using microarrays, we demonstrated that, among genes located on 12q13-q15, SAS/CDK4 were amplified in 6 PAISs, MDM2 and GLI in 5 and 4 PAISs, respectively, and that SAS/CDK4 and MDM2 were highly increased in the 2 ACTs. PDGFRA (located on 4q12) amplification was identified in 4 PAISs using microarrays, whereas amplification at the corresponding chromosomal region of this gene was detected only in 1 PAIS by conventional CGH. Additional gene amplifications that were revealed in 1 or 2 PAISs by microarrays include EGFR and INSR, MOS, MYC, CCND1, EMS1 and FGF3/FGF4. Our data demonstrate that genomic microarray-based CGH is a powerful tool for detection of gene amplification. In comparison with metaphase-based CGH, the microarray approach is more sensitive and has a higher resolution. Apolipoprotein E (apo E) and Lipoprotein(a) [Lp(a)] are considered as newer risk factors for CHD. Lp(a) has both atherogenic and thrombogenic potential and elevated levels have been associated with CHD. Apo E plays an important role in lipid metabolism. Apo E gene has 3 major isoforms E2, E3, and E4. These isoforms depending on their binding affinity to LDL receptor cause accumulation of lipids in the circulation and predispose an individual to CHD. We investigated the role of Lp(a) and apo E in high risk group subjects by analyzing serum Lp(a) levels and apo E polymorphism in subjects with elevated cholesterol levels (Group A, nϭ50), in angiographically verified CHD subjects (Group B, nϭ50) and in angiographically verified CHD subjects with elevated cholesterol levels (Group C, nϭ10) against healthy controls (nϭ90).
Lp(a) levels were estimated by ELISA which used antibodies against apolipoprotein B component of Lp(a). Genomic DNA was PCR-amplified using primers specific for the polymorphic apo E locus coding amino acids 112 and 158. Restriction enzyme digestion of the amplified DNA with HhaI and size-fractionation on 8% polyacrylamide gel was carried out for identification of the genotypes.
When compared against the controls Lp(a) levels were found to be statistically significant in Group A ( 2 ϭ5.49, dfϭ1, PϽ0.02) and Group B ( 2 ϭ4.48, dfϭ1, PϽ0.05). Apo E allele frequencies in the order 2, 3 and 4 were found to be 0.010, 0.880, 0.110 for Group A, 0.080, 0.830, 0.090 for Group B, and 0.040, 0.920, and 0.040 in the control group respectively. (4 allele frequency in Group A against 2ϩ3 was found to be statistically significant when compared against controls ( 2 ϭ5.4, dfϭ1, PϽ0.05). In Group C, elevated Lp(a) levels were observed in 4 and 4 alleles in 2 subjects.
The presence of elevated Lp(a) levels in subjects at high risk allows Lp(a) to be identified as a potential risk factor for CHD. The association of 4 alleles and CHD was not statistically significant. However, our study supports the hypothesis of increased prevalence of 4 allele with elevated cholesterol that may be one factor contributing to susceptibility to CHD.
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A Novel Enzymatic Approach for Nucleic Acid Mutation Detection: Applications to Congenital Adrenal Hyperplasia. Natalie Betz 1* , Anthony Killeen 2 , Daniel Kephart 1 , and John Shultz 1 , 1 Promega Corporation, Madison, WI, 2 Department of Pathology, University of Michigan, Ann Arbor, MI.
A novel enzymatic approach for nucleic acid mutation detection (READIT™-Reverse Enzyme Activity DNA Interrogation Test) has been developed, which is capable of analyzing a wide variety of sequence variations including single nucleotide polymorphisms (SNPs), insertions, deletions, and chromosomal translocations. The technology exploits the ability of READase™ polymerase to catalyze pyrophosphorolysis, the reverse of polymerization, in which the addition of inorganic pyrophosphate across the terminal phosphodiester bond liberates deoxynucleotide triphosphates (dNTPs). The released dNTPs are then converted to ATP in the presence of ADP and READase™ kinase, and the ATP is quantitated using firefly luciferase. The analysis of bi-allelic polymorphism utilizes two interrogation probes. The first probe is perfectly homologous to one form of the template (i.e. wild type) and is positioned such that its 3' end corresponds to the site to be interrogated. A second interrogation probe that hybridizes to the same template position, but whose 3' end corresponds to the alternative (i.e. mutant) form of the template is used. The perfect hybrid formed by the wild type and mutant interrogation probe and their respective templates will then serve as substrates for READase™ polymerase-mediated pyrophosphorolysis. CAH is a relatively common genetically complex autosomal recessive disorder in which mutations in the steroid 21-hydroxylase gene (CYP21) disrupt normal adrenal hormone synthesis. In addition to the expressed form of the CYP21 gene, a 95% homologous pseudogene (CYP21P) resides in tandem to CYP21. A variety of mutations are transferred from the pseudogene to the expressed gene by gene conversion events. These mutations include small deletions or point mutations that alter mRNA splicing, amino acid composition, or result in protein truncation. Approximately 20% of CAH is due to large gene deletions, in which an approximately 30 kbp region of the 21-hydroxylase locus is deleted. A PCR and READIT™ strategy has been developed to detect the 9 most common mutations present in CAH patients (which represent 95% of all SNP mutated CYP21 alleles). CYP21 is specifically amplified in two overlapping fragments and the presence of any mutation detected in a multiplex interrogation assay. The exact mutation present is then deconvoluted by further interrogation assays for each individual mutation site. The detection of target nucleic acid hybridized to a complementary capture probe is of central importance in genomic research and pathogen diagnostics. DNA sequencing on microchip arrays, gene expression analysis, cancer diagnostics, and molecular diagnosis of infectious agents are just a few examples of methodologies that require such detection. Current methodologies require attachment of enzymatic, fluorescent, chemiluminescent, or radioactive labels to the hybridized target. Furthermore, these methods require amplification of rare targets to detect low copies of a specific nucleic acid. These procedures are costly and time consuming, require complex instrumentation, and may introduce sample contamination. We have developed a novel detection method for DNA and RNA that does not require reporter molecule attachment or target amplification. The target nucleic acid is electrochemically detected using a soluble, metal mediator, tris(2,2'-bipyridyl) ruthenium(II) (Ru(bpy) 3 2ϩ ). When the appropriate potential is applied, Ru(bpy) 3 2ϩ oxidizes guanine via a catalytic cycle and current is produced. This method, unlike other electrochemical techniques, does not require the target to be directly wired to the electrode or the use of duplex specific, redox-active indicators.
The format currently in use is a 200 micron diameter ITO electrode on which an oligonucleotide capture probe is self-assembled. A nucleic acid target is allowed to hybridize to the capture probe and, after washing, Ru(bpy) 3 2ϩ is added. A potential is then applied and signal acquired from the catalytic oxidation of guanine. Use of hypoxanthine, a 1000 fold less electrochemically active base analogue of guanine, minimizes background current contributions from the capture probe. Using the 200 micron diameter electrode, 40 attomoles of a syntheric 21-mer oligonucleotide containing 5 guanines generated a signal of approximately 100nA over background. The specificity and sensitivity of the system is being optimized using synthetic oligonucleotide capture probes and targets, PCR products and mRNA from cultured cells.
The system is being optimized using synthetic oligonucleotides, PCR products, and mRNA from cultured cells. For example, successful hybridization has been achieved at the electrode using peptide nucleic acid probes, with 30% of the RNA target captured in 2 hours. The detector system can be readily multiplexed, and we are designing a 96 well microtiter plate with seven individually addressable test electrodes in each well. This design will allow the detection of five different sequence specific nucleic acid targets plus two controls per well or up to 672 analyses (480 samples and 192 controls) per plate.
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Amplifluor™ Detection System for Viral Target Screening and Quantitation. Sandra K. Randall 1 , Glenn A. Nardone 1 , Jay Ji 2 , Nate Lawrence 2 , and Mark Manak 2 , 1 Intergen Co. and 2 BBI Biotech Research Lab, Gaithersburg, MD.
Homogeneous and sensitive PCR based fluorescent detection assays suitable for high throughput viral screening are needed for screening blood and blood products. The desired closed-tube PCR assay for most viral load testing requires linearity between 10 2 and 10 9 copies/ml of blood, while assays for high throughput screening must be cost effective with sensitivity below 100 copies/ml of blood. Using the Amplifluor™ technology, we developed a competitive assay for the simultaneous detection of HBV DNA with an Internal Control (IC) that is suitable for quantitative real-time analysis with the capability for high throughput viral screening by endpoint analysis.
The Amplifluor™ system is based on the incorporation of energy transfer hairpin primers into the amplification products. During PCR, there is a common primer and two different gene specific Amplifluor™ primers. The excitation/emission wavelengths of the two Amplifluor™ primers allow for the simultaneous amplification and detection of HBV (FAM) and internal control (TAMRA) products. The internal control is used as a positive control for PCR amplification. When the primers are incorporated into the PCR product, the hairpin structure is opened and a fluorescent signal is generated enabling either "real-time" or "endpoint" analysis. Twenty thermocycled microtiter plates can be stacked on one fluorescent plate reader for automated endpoint analysis of many samples.
DNA extraction using the Qiagen BioRobot followed by PCR and detection enables rapid screening and quantitation of samples within a 4-hour period. HBV strains from human plasma samples were extracted and analyzed by both "real-time" and "endpoint" analysis. The "real-time" quantitation showed a six log range and a viral titer consistent (within 2-fold) with the Roche Amplicor HBV monitor test. The end-point analysis showed a similar trend with sensitivity below 400 copies/ml of blood. The HBV Amplifluor™ assay serves as a model for the development of sensitive viral assays compatible with screening of blood or blood products. ACLARA BioSciences is developing a new, flexible, modular assay format for high-throughput, multiplexed genetic analysis, in particular, SNP genotyping. Our approach is applicable to genome-wide scans for large-scale association studies and to panel-based screening of populations for predicted phenotype. In this new format, we combine a new probe labeling strategy (eTag™s) and existing, robust genotyping biochemistry such as Taq-Man™. In the eTag strategy, each probe of a multiplexed set is labeled with a unique, proprietary eTag, a molecular "tag" with a unique and characterized electrophoretic mobility. During target amplification, eTags are cleaved from the probes. These cleaved tags can be separated by electrophoresis, and genotyping information is obtained by interpretation of the resulting electropherograms. Additional sets of eTags can be used as internal control markers, and individual genotyping panels can be constructed by selection from a library of characterized eTags. The modularity of this strategy enables typing multiple samples with respect to a single panel of SNPs or bundling of multiplexed panels to scan for polymorphisms throughout a gene or genome. ACLARA is currently developing SNP assays using the eTag strategy for analysis on both commercial capillary electrophoresis instrumentation (ABI3100) and its own plastic, multichannel LabCard™ devices. Results will be presented for the development of multiplexed, parallel SNP-based genotyping of the pharmacogenetic targets ApoE and CYP2D6.
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The Importance of PCR in the Diagnosis of Mycobacterium tuberculosis Infection in Hematospermia: A Case Study. Pradeep V. Apte, Medicare Center, Indore 452001(M.P.), India.
A 27 year old unmarried male presented to our center with a complaint of persistent hematospermia. His semen on analysis showed gross blood and microscopic evaluation revealed innumerable red blood cells and a severe oligozoospermia. His routine semen culture was sterile and the initial tuberculosis work up of ZN smear for AFB, Mantaoux test and IgG, IgM, IgA antibodies were all negative and thus not indicating a M.tuberculosis infection.It was then decided to run a PCR for M.tuberculosis on his semen. A semen sample was collected and after processing was divided into two portions. One portion was cultured on Middlebrook medium with penta supplement and the other was subjected to DNA extraction by boiling.A PCR was run on the extracted DNA using the primers of the IS 6110 gene specific for M.tuberculosis followed by electrophoresis for identification of amplified product. The results revealed a faint 123 bp band indicating M.tuberculosis infection. After two weeks a second PCR was run on the DNA extracted from the Middlebrook culture medium which was strongly positive on electrophoresis, a ZN smear of the culture also showed several AFB. The patient responded very well to anti-tuberculer treatment as was evident after 4 weeks when his semen analysis report was absolutely normal with no blood and a normal sperm count. This study highlights the importance of PCR in the diagnosis of M.tuberculosis infection when all other parameters, especially the antibodies are negative. It also shows the utility of a culture enhancement on Middlebrook medium with penta supplement followed by PCR as a useful strategy for getting definite results for confirming M tuberculosis infection.
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A New Method for SNP Genotyping Based On Allele-specific PCR with Universal FRET Primers. Y. Khripin 1 , M. V. Myakishev 2 , S. Hu 2 , K. Lueders 2 , D. Hamer 2 , 1 Intergen, Gaithersburg, MD; 2 NIH, NCI, Bethesda, MD.
We have developed a new method for high throughput genotyping of single nucleotide polymorphisms (SNPs). The technique involves PCR amplification of genomic DNA with two tailed allele-specific primers that introduce priming sites for universal fluorescence resonance energy transfer (FRET) primers. The output of red and green light is conveniently scored using a fluorescence plate reader. The assay was validated on nine model SNPs representing all four possible types of single nucleotide substitutions. The new method is well suited for high throughput, automated genotyping because it requires only one reaction per SNP, it is performed in a single tube with no post-PCR handling, the same FRET primers are used for all analyses, and the instrumentation is inexpensive. Possible applications include multiple candidate gene analysis, genome-wide scans, and medical diagnostics. The method has been used to genotype 6 candidate genes for nicotine dependence and personality traits (DRD1, HTR2C, MAOA, HTR2A, HTR1B, DRD2, CHRNB2, CCK) on 2000 individual DNAs.
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The Importance of Considering MTHFR Genotype and Serum Folate Together with Homocysteine in Assessing the Cardiovascular Risk Attributable to Hyperhomocysteinemia: A Meta-analysis. P. Mastandrea, Laboratory Medicine, Ospedale Moscati, Avellino,Italy.
Hyperhomocysteinemia (Hyp) is an independent factor of cardiovascular risk (CVR). A thermolabile variant (C6773 T) of methylenetetrahydrofolate reductase (MTHFR) shows a decreased activity. Hyp increases because of decreased methionine synthesis. As Brattstrom indicated in his meta-analysis, data from studies of tHcy are heterogeneous, therefore it is difficult to apply standardized statistical tests. I aim to verify by this meta-analysis whether tHcy can be reduced to homogeneity by simple mathematical transformations and/or stratifying factors. I selected seventeen studies in Medline according to the following criteria: 1) stratification of the mean tHcy values by MTHFR genotypes and/or folate levels; 2) homogeneity of the tHcy cut-off points. All data were non-normally distributed. Reduction to normality was obtained by natural logarithmic transformation before statistical tests. Differences between mean tHcy values (with pooled standard errors) were tested by the fixed-and random-effect heterogeneity tests. These differences were calculated as: a) unstratified differences: (cases Ϫ controls); b) differences: (mutant MTHFR genotype (TT)) Ϫ ( wild-type (CC)) considered separately within cases and controls [1]; c) differences as mentioned in b) but stratified by serum folate [2]. Furthermore, a), b) and c) differences are net of basic values, that is, controls, the wild genotype alone and together with folate higher level respectively. A new membrane filter-based method for the rapid and simultaneous detection, identification, and enumeration of Escherichia coli using peptide nucleic acid (PNA) probes and a laser scanner within one working day is presented. PNA probes are DNA mimics with a polyamide backbone to which the individual nucleobases are attached. Their ability to hybridize to complementary nucleic acid targets with high specificity and rapid binding kinetics have opened new possibilities for molecular diagnostic assays. The method is based on traditional membrane filtration technique for capturing microorganisms from large sample volumes. Following sample filtration, the membrane filter was incubated for 5 hours on growth medium to allow formation of micro-colonies. The micro-colonies were then analyzed directly on the membrane filter by fluorescent in situ hybridization using fluorescently-labeled PNA probes targeting a species-specific 16S rRNA sequence. Using an array scanner with 5 m resolution, the entire surface of a 25 mm membrane filter was analyzed for the presence of fluorescent micro-colonies within 8 minutes, thereby providing rapid and simultaneous detection, identification, and enumeration of E. coli. A rapid phenotypic susceptibility assessment of E. coli has also been performed by the use of antibiotics in the growth medium. This new method is promising for a variety of different applications within clinical and industrial microbiology. Microarray-based mRNA expression profiling is a powerful functional genomics tool, but suffers from a major limitation of discordance with protein expression levels. Conventional approaches to protein measurements are either too expensive or lack throughput for simultaneous monitoring of expression levels of many proteins in parallel. Rolling Circle Amplification (RCA) is emerging as the signal amplification method of choice for DNA and RNA microarrays, since RCA uniquely allows target recognition, amplification, and detection in situ on the microarray. We have recently developed an adaptation of rolling circle amplification (RCA) for the detection of antibody bound to antigen, termed "immunoRCA". In immunoRCA, the 5' end of an oligonucleotide primer is attached to an antibody; thus, in the presence of circular DNA, DNA polymerase, and nucleotides, the rolling circle reaction results in a concatamer of circle DNA sequence copies that remain attached to the antibody. The amplified DNA can be detected by hybridization of complementary oligonucleotide probes. ImmunoRCA, therefore, represents a novel approach for signal amplification of antibody-antigen recognition events on microarrays. We have previously shown that ImmunoRCA enables analyte detection on immunomicroarrays with a sensitivity limit of 100 zeptomoles and a dynamic range of greater than 4 logs using a conventional microarray scanner (Schweitzer et al., Proc. Natl. Acad. Sci. (USA), in press.). Results will be presented from a retrospective study involving 80 allergic patients that demonstrate that the clinical accuracy of ImmunoRCA detection of allergen specific IgE on microarrays of allergen extracts is comparable to conventional immunoassay when compared to the skin prick test. We have also constructed a microarray consisting of approximately 50 different antibodies to cytokines, chemokines, and growth factors. Using ImmunoRCA for signal amplification, pg/ml sensitivity has been demonstrated for simultaneous detection of multiple proteins on this array. A two-color adaptation of ImmunoRCA has also been developed that permits simultaneous measurement on a microarray of protein levels from two samples in a manner analogous to RNA expression profiling.
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Post-PCR Detection and Discrimination of the CYP2C9*1, CYP2C9*2, and CYP2C9*3 SNPs Using Gene Probes. Marc Goldford, John Backus, and Mark Triscott, Sigma Diagnostics, St. Louis MO.
The cytochrome P450 enzyme 2C9 segregates into several alleles due to single nucleotide polymorphisms (SNPs). This work undertook the development of a simple, inexpensive, and timely diagnostic technique for the CYP2C9*1 wild-type and the CYP2C9*2 (nt416) and CYP2C9*3 (nt1061) mutant SNPs using microtiter plate capture of biotinylated amplicons with subsequent identification by fluoresceinated DNA probes. The genotypes of 25 random donors were first determined by restriction endonuclease/gel electrophoresis using the method and primer sets of Wang (Pharmacogenetics 5: 37, 1995) . One homozygous mutant, seven heterozygotes, and seventeen homozygous wild-types were found for nt416, and two heterozygotes and twenty-three homozygous wild-types for nt1061. These DNA samples were then amplified with primers after Nasu (Pharmacogenetics 7: 405, 1997) for nt416 and after Steward (Pharmacogenetics 7: 361, 1997) for nt1061 detection. Both reverse primers were 5' biotinylated in this study. Amplicons were bound in duplicate to streptavidin coated plates, denatured, and washed to remove the unmodified complementary DNA strand from each duplex. One well of each pair was then hybridized with a 15 bp fluoresceinated wild-type probe solution containing unlabelled competitor mutant probe, and the other well with a 15 bp fluoresceinated mutant probe solution containing unlabelled competitor wild-type probe. After hybridication OD 450 was developed with anti-fluorescein antibody HRP conjugate and TMB substrate. The ratios of WT/Mutant OD 450 were calculated, and cleanly segregated to Ͼ10 (homozygous WT), 0.7 to 2.0 (heterozygote), or Ͻ0.2 (homozygous mutant). The genotypes determined by probe assay replicated the results determined by RE/GE for both loci, demonstrating 100% sensitivity and 100% specificity. This plate capture/probe detection method requires minimally expensive reagents and can be completed in two to three hours, can be automated with readily available microtiter plate instruments, and can simultaneously discriminate multiple loci in a "macroarray" format. Peptide Nucleic Acids (PNAs) are a unique class of molecules that are DNA mimics and demonstrate improved hybridization kinetics and specificity. The non-charged backbone of PNA allows hybridization to be performed under low salt conditions that are denaturing for rRNA secondary structure but favorable for PNA-RNA hybridization. rRNA is a well established target for molecular diagnostic assays due to its high cellular abundance, universal distribution, and use as a phylogenetic marker. Using the publicly available sequence databases, species-specific rRNA sequences have been identified and complementary PNA probes synthesized. The PNA probes were labeled with fluorescent dyes and used to develop a fluorescent in situ hybridization method (PNA FISH) for identification of microorganisms. The PNA FISH method uses universal fixation and hybridization conditions for gramnegative and gram-positive bacteria, as well as yeasts. PNA probes labeled with different fluorescent dyes were applied individually, or in a multiplex assay in which up to four differently labeled PNA probes were used simultaneously with a mixed population of cells. The fluorescent dyes which have been used include fluorescein, cy 3, cy 5, coumarin, rhodamine, and alexa dyes, Examples using species-specific probes for Escherichia coli, Salmonella enterica, Pseudomonas aeruginosa, and Staphylococcus aureus, will be shown in both single and multiplex assays.
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Transcriptome Analysis Based on Isothermal Sequence Amplification. Kiyoshi Yasukawa and Takahiko Ishiguro, Tokyo Research Laboratories, Tosoh Corporation, Kanagawa 252-1123, Japan. As the full-length of sequences of genomes of several species including human genome of 3 billion bp come into view, the post-genomic analysis has already started. Despite the advances in computational prediction of unidentified genes, it is still difficult to accurately identify genes from genomic sequences themselves, and transcriptome analysis should be based on the experimental data.
In this study, we have devised a novel method to identify genes throughout genomes based on isothermal sequence amplification. The complete genome or its part is divided into fragments of approximately 100 to 200 bp. Based on the nucleotide sequences of each fragment, sense and anti-sense DNA primers are synthesized. If the amplification occurs using the primers, the fragment is identified to be the entire transcriptional region. In the model experiments, the 900 bp genomic sequences of the yeast pichia pastoris was divided into 5 fragments of 180 bp. The transcriptional region of the sequences had been already known. By the isothermal RNA amplification method, TRC (transcription-reverse transcription concerted amplification), we found that the amplification was specific to the fragments that were entire transcriptional regions. We also demonstrated that the amplification could be monitored by the INAF (intercalation activating fluorescence) probe in the course of the TRC reaction. It was found that the sensitivity in TRC was 10 times higher than that in RT-PCR. Genomic DNA contamination led to RT-PCR amplification even in the absence of the targeted mRNA, while such undesired amplification was not observed in TRC. It was also found that 30-minute incubation was enough for the detection of the targeted mRNA in the TRC reaction whereas 2 to 3 hours were required in RT-PCR.
The present results suggest that the fluorescence real-time monitoring of isothermal sequence amplification with INAF probes provides a widely applicable method for the upcoming transcriptome analysis and its automation.
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Evaluation of Semi-Automated Hepatitis C RNA Quantitative Assays Using QIAGEN BIOROBOT RNA Isolation and COBAS AMPLICOR HCV MONITOR Detection. Russell E. Baumann and Michael A. Lewinski, Quest Diagnostics' Nichols Institute.
An automated viral RNA isolation platform (QIAGEN BIOROBOT 9604) has been optimized, combined with the COBAS AMPLICOR HCV MONITOR v2.0 test, and evaluated for performing semi-automated hepatitis C (HCV) viral load determinations with clinical specimens. The QUEST HCV RNA v1.0 isolation protocol, a modified version of QIAGEN's QIAamp 96 Viral RNA procedure, automates the preparation of RNA in a manner equivalent to the COBAS AMPLICOR HCV MONITOR v2.0 manual procedure. A recently validated second generation protocol (QUEST HCV RNA v2.0) additionally automates the transfer of RNA to the COBAS' circular A-rings. The first generation assay (Quest v1.0 ϩ COBAS v2.0) exhibited a dynamic range of 1000 to 1,000,000 HCV (type 1b) copies/ml. Patient viral loads determined using the first generation assay correlated well with the manual HCV MONITOR v1.0 test (r 2 ϭ 0.98, n ϭ 109). The second generation assay (Quest v2.0 ϩ IU-calibrated COBAS v2.0) exhibited a dynamic range of 600 to 600,000 HCV (type 1a) IU/ml. Patient viral loads determined using the second generation assay correlated well with the first generation test (r 2 ϭ 0.99, n ϭ 135). Mean inter-assay precision, calculated from results for the COBAS Low and High Positive and BBI HCV Accurun Series 300 controls, was 33% (nϭ179) for the first generation assay and estimated at 26 % (nϭ12) for the second generation assay. In comparison, COBAS v2.0 runs performed using manually prepared RNA had mean precision estimates of 32% (nϭ44), indicating that equivalent precision is attained with the automated RNA isolation protocols. The semi-automated hepatitis C RNA quantitative assay formats offer the advantage of automating the laborious RNA isolation and transfer steps, without adversely affecting the precision of the COBAS HCV v2.0 test while maintaining a 3-log dynamic range of HCV viral load determination. The successful combination of automated HCVRNA isolation and detection platforms may enhance the ability of clinical laboratories in meeting high throughput demands for HCV viral load determinations.
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Pyrosequencing: Performance and Application to Factor V Leiden Determination. Lena Nyberg 1 , Anders Alderborn 1 , William Strandberg 2 , Ingrid Muldin 1 , Claes Wadelius 2 , 1 Pyrosequencing AB, Uppsala, Sweden; 2 Department of Genetics and Pathology, University of Uppsala, Uppsala, Sweden.
Pyrosequencing™ is a real-time sequencing method based on synthesis detection. Pyrophosphate (PPi), released during nucleotide incorporation by DNA polymerase, is detected as light produced by an enzyme cascade system. Pyrosequencing AB (Uppsala, Sweden) recently introduced the PSQ 96™ System, in which 96 different Single Nucleotide Polymorphism (SNP) samples are analyzed in parallel in less than 15 min. All reagents needed for performing a Pyrosequencing analysis in the PSQ 96 System are provided in an SNP Reagent Kit (enzymes, substrates and nucleotides), and dedicated SNP software delivers genotype and a quality assessment for each sample. Template preparation for analysis begins with a standard PCR reaction, followed by immobilization onto magnetic beads, denaturation by alkali and annealing of a sequencing primer.
The G1691A mutation in the coagulation factor V gene (Factor V Leiden) is the most common cause of resistance to activated protein C. Due to the increased risk for venous thrombosis caused by this mutation, the genotyping of this position has become clinically important. We have investigated this mutation by Pyrosequencing. All three genotypes were easily distinguished and correctly determined, proving that Pyrosequencing offers a reliable method for genotyping of the Factor V Leiden mutation. Cisplatin (cis-diamine dichloroplatinum) and gemcitabine (2', 2'-difluorodeoxycytidine) are effective chemotherapeutic agents for the treatment of solid tumors. Gemcitabine is activated through phosphorylation by deoxycytidine kinase (dCK) and can be incorporated into DNA or RNA, inhibiting further elongation; it is inactivated by deoxycytidine deaminase (dCDA), reducing cytotoxic activity. Gemcitabine also inhibits ribonucleotide reductase (RRM1, RRM2) activity and decreases the deoxynucleoside triphosphate concentrations. Cisplatin creates inter-stand DNA crosslinks, inhibits polymerases and blocks replication and transcription. It also activates the DNA damage repair mechanism, through ERCC1 (Excision repair cross complementation group 1) decreasing sensitivity to the drug.
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Target Gene Expression Analysis in Fresh Tumor Biopsy Specimens from
During Phase II clinical trial of the combination of cisplatin and gemcitabine for patients with advanced breast cancer, fresh tumor biopsies (21 samples; 10-20 mg of tissue) were obtained from sites of recurrent disease. Expression levels of six genes from these tumor samples (b-act, ERCC1, dCK, dCDA, RRM1, RRM2) were analyzed by QRT-PCR using a robotic PCR technique. A denaturing polyacrylamide gel separates the fluorescent dyelabeled amplicons using the ABI 377 DNA sequencer in GeneScan mode. The result of this analysis yields a ratio of the target gene divided by the b-actin expression in the sample.
There is a large degree of variation from patient to patient in mRNA levels. Separate analysis of (RRM2) and (RRM1) shows a 50% decrease in RRM2 level after therapy, only minor changes were observed for RRM1. Some changes were also seen in the dCK expression level; changes in the dCDA level are inconclusive.
Assessment of the predictive value of these mRNA levels for treatment response is in progress. (CA 62505) In order to realize the full potential of SNPs it is essential to develop practical, accurate, and high-throughput methods to genotype them. Although a number of high-throughput SNP genotyping assays have been developed, including the oligonucleotide ligation assay (OLA), minisequencing, TaqMan, and dynamic allele specific hybridization (DASH), the requirements of simplicity and low-cost have not been adequately met. To address these issues, we have developed a method that we refer to as Melting curve SNP (McSNP) genotyping, which is less expensive ($0.12/genotype reagent cost) and simpler to use than existing high-throughput genotyping assays. McSNP combines a classic approach for discriminating alleles, restriction enzyme digestion, with a newer method for detecting DNA fragments, melting curve analysis (MCA). MCA is performed by slowly heating DNA fragments in the presence of the double stranded DNA (dsDNA) specific fluorescent dye SYBR green I. As the particular fragment is heated through its melting temperature (T m ), fluorescence rapidly decreases due to denaturation of the dsDNA. We show that it is possible to discriminate the composition of simple mixtures of DNA fragments such as those that result from restriction enzyme digestions of short PCR products and insertion/deletion (indel) polymorphisms. Using the Hybaid DASH Machine (Hybaid USA, Franklin, MA) 96 samples can be analyzed and automatically scored in under 15 minutes. Since it is possible to engineer an artificial restriction site through the use of mismatched primers, McSNP is applicable to almost any SNP and not just those with natural restriction sites. In total, we have generated over 15,000 genotypes for 40 autosomal and Y-chromosome SNPs. 853 of these genotypes were confirmed by other methods, and we estimate a 98.9% first run accuracy rate. Our results clearly demonstrate that McSNP is a simple, fast, inexpensive, and accurate means of genotyping SNP variation. This research is supported by grants from NIH/NIDDK (DK53958) and NIH/NHGRI (HG02154). Factor V Leiden is a single-point mutation in the factor V gene (G1691A) that incorporates arginine instead of glutamine at amino acid residue 506 (R506Q).This substitution prevents a peptide bond in the coagulation molecule from being cleaved by activated protein C (APC). During normal homeostasis, APC limits clot formation by proteilytic inactivation of factor Va and VIIIa. Heterozygotes carriers have an increased risk of thrombosis of up to seven-fold. Homozygotes have an 80-fold increased risk. Most homozygotes will experience at least one episode of thrombosis during their lifetime.
The usual method for detecting factor V Leiden is to amplify by PCR a portion of the gene containing the mutation and then digest the products with a restriction enzyme that cuts only the wild-type sequence. Size separation of digested products by gel electrophoresis distinguishes wild-type from homozygous and heterozygous mutant genotypes. We are describing a rapid mutation analysis method that requires polymerase chain reaction and DNA sequencing manipulations.
PE Applied Biosystems DNA sequencers detect fluorescence from four different dyes that are used to identify the A, C, G and T extension reactions. We used this method to sequence a amplified portion of the gene containing the mutation from heterozygotes and homozygotes carriers. To the homozygotes carriers, sequence data obtained with big-dye terminators and a template isolated showed a pure DNA sequence. To the heterozygotes carriers, more than one sequence was present in an electropherogram. This resulted in ambiguities (Ns) in the basecalling. Careful examination of the data showed that the two sequences were identical, except at the base 1691 of the gene where both peaks, G and A, could be seen at the same level.
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Automated Detection of the Factor V Leiden Mutation Using MALDI-TOF Mass Spectrometry on the MassARRAY System. E. Lau 1 , J. Leushner 2 , and M. Patnaik 1 , 1 Specialty Laboratories and 2 SEQUENOM Inc.
The Factor V Leiden mutation has been shown to be the most common genetic risk factor for venous thrombosis. This mutation is a single nucleotide polymorphism(SNP) at position 1691 of exon 10 of the gene. This SNP is a G/A transition resulting in an Arg/Gln substitution in the protein. We have developed an automated method which is both highly sensitive and accurate to detect the Factor V Leiden mutation in genomic DNA from whole blood by PCR amplification followed by the MassEXTEND reaction and then detection by MALDI-TOF Mass Spectrometry(MS). MALDI-TOF MS separates and detects molecules by the intrinsic physical property of mass-to-charge ratio (m/z), eliminating the need for gel electrophoresis or fluorescent labeling.
We have compared the method with the standard procedures of restriction enzyme digestion and gel electrophoresis in blind experiments. Detection was carried out on the SEQUENOM MassARRAY platform. In 212 patients tested with deep venous thromboses, there were 10 heterozygotes and 99 homozygotes determined to have the Factor V Leiden mutation. When data from the standard methods were compared with that obtained using the MassARRAY platform there was a 100% concordancy between the two methods. Unlike standard methods, the MassARRAY platform is completely automated and error free. The robustness of this automated method should make it a useful routine test for the factor V Leiden mutation in clinical laboratories with high throughput needs and demands for improved accuracy.
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High Temperature Magnesium (Mg 2؉ )-activated Reverse Transcription by Thermostable DNA Polymerases. Edward Smith, Alice Wang, Christopher L. Sigua, Nancy Schö nbrunner, Thomas W. Myers, and David H. Gelfand.
Thermostable DNA polymerases have been shown to exhibit reverse transcription (RT) activity, i.e. cDNA synthesis from an RNA template. However, with thermostable DNA polymerases, efficient RT activity has only been found in the presence of Mn 2ϩ . There are some drawbacks associated with Mn 2ϩ -activated RT activity. For instance, the divalent metal ioncatalyzed hydrolysis of RNA is increased with Mn 2ϩ and the mis-incorporation rate of the DNA polymerase during PCR amplification is higher in the presence of Mn 2ϩ when compared to reactions using Mg 2ϩ as the divalent metal ion activator.
We have found point mutations in the polymerase domain of rTth DNA Polymerase that alter the reverse transcription associated divalent metal ion activator requirements. These mutant DNA polymerases have significantly improved efficiency over wild-type enzyme using either Mg 2ϩ or Mn 2ϩ ion activation. Certain mutations result in a 1000-fold increase in Mg 2ϩ -activated RT-PCR efficiency when compared to wild-type enzyme activated with Mg 2ϩ , while they remain equal to or better than wild-type enzyme and Mn 2ϩ activation. With Mn 2ϩ -activation, the mutant enzymes exhibit increased RT activity with much shorter than usual RT incubation times required, as low as 5 minutes. We have utilized the melting temperature profiles of amplicon as an indicator of fidelity. Profiles which are more distinct and have an increased melting temperature are indicative of more perfectly matched complements and thus suggest higher fidelity. Performing Mg 2ϩ -activated RT-PCR with these novel mutant enzymes yields PCR product with elevated and more distinctive melting temperature profiles than PCR product derived from Mn 2ϩ -activated RT-PCR with the wild-type enzyme. These results suggest that the mis-incorporation rate is lower for the Mg 2ϩ -activated RT-PCR with these novel mutant enzymes and that a significantly higher fidelity is being achieved. Efficient reverse transcription with these thermophilic and thermostable DNA polymerases may prove useful in a wide range of diagnostic and research applications.
